EJCTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hazekamp, M.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hazekamp, M.G.

Eur J Cardiothorac Surg 2006;30:33-34
© 2006 Elsevier Science NL

Editorial comment

A mechanical prosthesis for pulmonary valve replacement?

M.G. Hazekamp *

Department of Cardiothoracic Surgery, D6-26, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands

* Tel.: +31 71 5262348; fax: +31 71 5248284. (Email: m.g.hazekamp@lumc.nl).

The first 20% of the full text of this article appears below.

Usually, for pulmonary valve replacement and RVOT reconstruction, homografts or valved xenografts are used. This is true both for pediatric and adult patients.

Pediatric cardiac surgeons have a tradition of using homografts or biological valved conduits and are inclined to choose the same type of prosthesis when performing pulmonary valve replacement in adult patients with congenital heart disease. The choice for a homograft or xenograft is based on various arguments.

Mechanical valve prostheses carry a life-long risk of thrombo-embolic events even with proper anticoagulative therapy. At the same time anticoagulation has a certain incidence of bleeding complications. Young female patients with child wish are better off without anticoagulation. Furthermore, several reports have reported thrombosed mechanical valves in pulmonary position. The risk of one or more reoperations to replace the homograft or xenograft is usually considered to be sufficiently low to justify the decision of not using a mechanical prosthesis.

The number of grown-up patients with congenital heart disease (GUCH's) is expected to grow in . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.